David Shrom

Deficient Neurogenesis in Forebrain-Specific Presenilin-1 Knockout Mice Is Associated with Reduced Clearance of Hippocampal Memory Traces

Ruiben Feng, Claire Rampon, Ya‐Ping Tang et al. · Neuron · 2001 · 468 citations · Full text

Deficient Neurogenesis, Developmental Biology, Developmental Cognitive Neuroscience +12

Forebrain degeneration and ventricle enlargement caused by double knockout of Alzheimer's <i>presenilin-1</i> and <i>presenilin-2</i>

Ruiben Feng, Huimin Wang, Jianlin Wang et al. · Proceedings of the National Academy of Sciences · 2004 · 123 citations · Full text

Neurochemical Biomarkers, Social Sciences, Early-onset Familial Alzheimer +18

Detection and prediction of periodic patterns by the retina

Gregory W. Schwartz, Rob C. Harris, David Shrom et al. · Nature Neuroscience · 2007 · 118 citations

Machine Vision, Image Analysis, Ophthalmology +7

Efficacy of ixekizumab compared to etanercept and placebo in patients with moderate‐to‐severe plaque psoriasis and non‐pustular palmoplantar involvement: results from three phase 3 trials (<scp>UNCOVER</scp>‐1, <scp>UNCOVER</scp>‐2 and <scp>UNCOVER</scp>‐3)

Alan Menter, Richard B. Warren, Richard G. Langley et al. · Journal of the European Academy of Dermatology and Venereology · 2017 · 73 citations · Full text

Continuous dosing versus interrupted therapy with ixekizumab: an integrated analysis of two phase 3 trials in psoriasis

Andrew Blauvelt, Kim Papp, Howard Sofen et al. · Journal of the European Academy of Dermatology and Venereology · 2017 · 64 citations · Full text